ArticleJournal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing2026
A Comparative Policy Analysis of HPV Vaccination Guidelines: Actors, Context, Content, and Process Across Eight Countries.
Article in Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo compare HPV vaccination policies across eight countries and examine how actors, context, policy content, and implementation processes influence program performance and coverage outcomes.
designComparative policy analysis using a qualitative cross-case document analysis. DATA SOURCES: Official national HPV vaccination guidelines, technical advisory documents, WHO and UNICEF monitoring reports, and peer-reviewed literature published between January 2006 and December 2024. Sources were identified through structured searches of PubMed, CINAHL, Scopus, and Web of Science.
methodsThe Health Policy Triangle framework guided analysis across four domains: Actors, Context, Content, and Process. A standardized data extraction template was applied across eight countries: Australia, Brazil, Japan, Nigeria, Rwanda, Sweden, the United Kingdom, and the United States. Data were synthesized in comparative matrices and analyzed using iterative cross-case analysis, with coding verified by a second reviewer.
resultsFive policy archetypes were identified: school-based universal programs, decentralized federal models, gender-neutral vaccination strategies, resource-constrained but high-performing systems, and the policy recovery model exemplified by Japan. School-based delivery supported by nursing and school health workforces consistently achieved the highest and most equitable coverage. Rwanda achieved 98% coverage despite a girls-only, donor-supported model, indicating that governance quality and community trust may outweigh policy design alone. The global transition to single-dose HPV vaccination schedules requires country-specific adaptation that accounts for population-based eligibility exceptions and evidence gaps, including the absence of clinical trial data on single-dose protection in males and against non-cervical HPV-associated diseases.
conclusionHPV vaccination outcomes are shaped by governance structures, implementation capacity, nursing workforce infrastructure, and public trust. Strengthening school-based delivery, expanding single-dose schedules where supported by evidence, and investing in nursing-led outreach are critical to accelerating progress toward WHO cervical cancer elimination targets. IMPACT: Nurses are central to HPV vaccination delivery worldwide. This analysis provides evidence to support nursing leadership in advocating for school-based models, workforce investment, and equitable immunization strategies across diverse health system contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.